Myocardial dysfunction & atrial disorders
What's new in heart failure management
iHF offers a wealth of constantly updated information on heart failure drugs and device solutions to improve patient care.
-
-
Myocardial dysfunction & atrial disorders
Another failure for spironolactone in cardiovascular prevention among dialysis patients
-
News
iHF at EuroPCR 2025 - Improving heart function – with a transdisciplinary educational approach
-
Myocardial dysfunction & atrial disorders
Heart failure with improved ejection fraction: finerenone effective in reducing cardiovascular risk
-
Myocardial dysfunction & atrial disorders
Real-world data on sudden cardiac arrest and WCD therapies in high-risk patients
-
Myocardial dysfunction & atrial disorders
Guideline-Directed Medical Therapy and Left Ventricular Ejection Fraction: from static measure to trajectories of change
-
Coronary artery disease
Extracoronary Calcification Linked to Increased Risk of Heart Failure with Preserved Ejection Fraction
-
Coronary artery disease
Following myocardial infarction, early addition of Ezetimibe to high-intensity statin therapy reduces cardiovascular risk
-
News
iHF (Improving Heart Function) sessions on heart failure at EuroPCR 2025
-
Valve disease
Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
-
News
ACC.25 Clinical Science Round-Up: Unraveling Complexities in Cardio-Renal-Metabolic Disease and Structural Heart Care
-
Myocardial dysfunction & atrial disorders
In heart failure, echocardiographic parameters of right ventricular function are powerful tools to predict renal failure
-
Editorial
Don't Skip a Beat: The Power of Medication Adherence in Cardiovascular Health
-
Editorial
Editorial from Emanuele Barbato
-
Interview
An interview with Giuseppe Rosano
-
Editorial
Editorial from Izabella Uchmanowicz
-
Interview
An interview with Emanuele Barbato
